The Prevention of Thromboembolic Complications Associated With Coil Embolization

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-02-10

Study Completion Date

2020-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

NCT01361386

Acute Coronary Syndrome

COMPLETED

Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk

NCT02960126

Atrial Fibrillation

UNKNOWN PHASE3

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

NCT05257824

Aneurysm Cerebral Endovascular Procedures

COMPLETED PHASE4

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

NCT02144831

Transient Ischemic Attacks Minor Stroke

WITHDRAWN PHASE4

Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling

NCT02224131

Embolic Stroke

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thromboembolic Stroke Aspirin Clopidogrel Coil Embolization Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aspirin Group

patients were prescribed 75 mg/day of either aspirin for 6 months

Aspir-Low Pill

Intervention Type DRUG

patients were prescribed 75 mg/day of either aspirin

Clopidogrel Group

75mg/day prescribed for 6 months

Aspir-Low Pill

Intervention Type DRUG

patients were prescribed 75 mg/day of either aspirin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aspir-Low Pill

patients were prescribed 75 mg/day of either aspirin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All the patients enrolled in the study underwent MRI and Angiography.
* Participants included in the study were confirmed on assessment, and verified for ruptured aneurysm by imaging using either computed tomography (CT) or MRI.